Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

Share Price is delayed by 15 minutes
Get Live Data
64.00    2.00 (3.23%)
Bid:
63.00
Ask:
65.00
Spread: 2.00 (3.175%)
Market Cap: £15.59m
MYX Live PriceLast checked at - London Stock Exchange

Intraday Mycelx Di Share Chart

Operational Update & Directorate Change

14 May 2013 07:00

RNS Number : 6148E
MyCelx Technologies Corporation
14 May 2013
 



MyCelx Technologies Corporation

("MyCelx" or the "Company") (AIM: MYX)

14 May 2013

 

Operational Update & Directorate Change

 

MyCelx Technologies, Inc (AIM: MYX), the clean water technology and engineering company providing patented solutions to the Oil and Gas industry and other commercial industrial markets worldwide, today announces an operational update and directorate change.

 

Operations

 

MyCelx is pleased to confirm that it continues to trade in line with market expectations.

 

The Company's expansion in recent years means that it has now outgrown its current head office in Gainesville, Georgia, and has recently acquired new offices in Duluth, Georgia, to house its corporate headquarters, laboratory and production facilities, and research and development department. The new head office will be operational from the beginning of June 2013.

 

In addition, the Company's Houston engineering and technology demonstration centre is now fully operational, and includes a demonstration system consisting of a MyCelx Advanced Coalescer, REGEN and Polisher. During the week of the global industry oil and gas Offshore Technology Conference which took place in Houston from 6 May to 10 May, the Company hosted a number of major international oil companies at its Houston office to view the MyCelx demonstration system in live operation. A video of the system in operation will shortly be available on the Company's website.

 

The Company has also further strengthened its capabilities with the addition of new engineering and sales personnel in the Middle East, Houston and London.

 

Directorate Change

 

The Board of MyCelx announces that it has been informed by John Mansfield Sr., Non-Executive Vice Chairman, of his wish to retire as a Director with immediate effect for health reasons. 

 

The Board has resolved to bestow upon Mr Mansfield the title of Chairman Emeritus upon his retirement.

 

Tim Eggar, Chairman, said: "The Board wishes to express its deepest appreciation to Mr Mansfield, the Company's former Chairman and co-founder, for his service to the Company. Mr Mansfield was instrumental in the Company's early development, providing funding and expertise to support its growth into a revolutionary oil-free water technology company with customers across the world."

 

Brian Rochester, Non-executive Director, has been appointed as Chairman of the Compensation Committee, and Swinton Griffith, Non-executive Director, has been appointed as a member of the Governance and Nomination Committee, with effect 15 May 2013.

 

 

- ends -

 

For further information please contact:

MyCelx Technologies Corporation

Connie Mixon, CEO

Mark Clark, CFO

Tel: +1 888 306 6843

 

Numis Securities Limited

Corporate Finance

Stuart Skinner

Jamie Loughborough

 

Corporate Broking

James Black

Ben Stoop

Tel: +44 20 7260 1000

 

Pelham Bell Pottinger

Mark Antelme

Nick Lambert

Tel: +44 20 7861 3232

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGMKLFLGFZM
Date   Source Headline
3rd Jun 20267:00 amRNSAppointment of Non-Executive Director
12th May 20267:00 amRNSNew Gulf of Mexico Lease Award with Super Major
7th May 20267:00 amRNSFinal Results for the Year Ending 31 December 2025
16th Feb 202610:46 amRNSDirector Dealing
20th Jan 20267:00 amRNSTrading Update
22nd Dec 202511:27 amRNSHolding(s) in Company
7th Nov 20252:51 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTrading Update & $3.9m Project Award
1st Oct 20257:00 amRNSHolding(s) in Company
23rd Sep 20255:00 pmRNSResult of Annual Meeting
23rd Sep 20257:00 amRNSAppointment of New Chairman and Succession
17th Sep 20257:00 amRNSHalf Year Results Statement
11th Sep 20257:00 amRNSClosure of Restricted Stock Line
22nd Aug 20257:00 amRNSMailing of Notice of 2025 Annual Meeting
20th Aug 20257:00 amRNSOpening of $500,000 Line of Credit
17th Jul 20257:00 amRNSTrading Update
10th Jun 20257:00 amRNSMailing of 2024 Annual Report
21st May 20253:25 pmRNSDirector Dealing
19th May 202511:33 amRNSHolding(s) in Company
15th May 202511:21 amRNSHolding(s) in Company
12th May 20257:00 amRNSFinal Results for the Year Ending 31 December 2024
6th May 20257:00 amRNSPFAS Contract Award
1st May 20257:00 amRNS-REPA Announces Actions to Combat PFAS Contamination
10th Apr 20257:00 amRNSGrant of Share Options
7th Apr 20257:00 amRNSOperational and Trading Update
30th Jan 20257:00 amRNSChange of Adviser
6th Jan 20257:00 amRNSYear-end Update
29th Oct 20247:00 amRNSProject Award
24th Sep 20247:00 amRNSHalf Year Results Statement
23rd Sep 20247:00 amRNSTrading Update
6th Sep 202411:54 amRNSHolding(s) in Company
5th Sep 20245:17 pmRNSHolding(s) in Company
30th Aug 20247:00 amRNSBroker Option
23rd Aug 202411:05 amRNSDirector Dealings & Total Voting Rights
23rd Aug 20247:00 amRNSProposed Placing and Subscription
19th Jul 202410:36 amRNSPFAS Update
9th Jul 20242:23 pmRNSResult of AGM
9th Jul 20241:39 pmRNSHolding(s) in Company
4th Jun 20247:00 amRNS2023 Annual Report & Notice of 2024 Annual Meeting
21st May 20247:00 amRNSDirector Dealing
16th May 20247:00 amRNSFinal Results for the Year Ending 31 December 2023
24th Apr 20247:00 amRNSBusiness Update
11th Apr 20247:00 amRNSEPA Publishes National Drinking Water Standards
26th Mar 20243:30 pmRNSDirector Dealing
26th Mar 20247:00 amRNSDirector Dealing
22nd Mar 20247:00 amRNSDirector Dealing
21st Mar 20247:00 amRNSDirector Dealing
18th Mar 20247:00 amRNSGrant of Share Options to Chief Financial Officer
4th Mar 20247:00 amRNSSaudi Arabia Business Operation Sale Completion
22nd Feb 20247:02 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.